Literature DB >> 16750347

Comorbid substance-use in schizophrenia: relation to positive and negative symptoms.

A Talamo1, F Centorrino, L Tondo, A Dimitri, J Hennen, R J Baldessarini.   

Abstract

As substance use disorders (SUD) are common in schizophrenia patients, we tested the hypothesis that comorbid patients (SUD[+]) have more positive vs. negative symptoms than non-comorbid (SUD[-]) patients. From reports identified by literature-searching we compared Positive and Negative Syndrome Scale (PANSS) ratings in schizophrenia patients with and without SUD using meta-analytic methods. Among 9 comparisons (N=725 subjects), SUD[+] patients were more often men, and abused alcohol>cannabis>cocaine. SUD[+] patients had very significantly higher PANSS-positive, and lower PANSS-negative scores. Comorbid SUD in schizophrenia patients was associated with male sex and higher PANSS positive to lower negative scores. Cause-effect relationships remain to be clarified.

Entities:  

Mesh:

Year:  2006        PMID: 16750347     DOI: 10.1016/j.schres.2006.04.004

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  18 in total

1.  Motivation deficits and use of alcohol and illicit drugs among individuals with schizophrenia.

Authors:  Amber L Bahorik; Catherine G Greeno; Gerald Cochran; Jack R Cornelius; Shaun M Eack
Journal:  Psychiatry Res       Date:  2017-04-05       Impact factor: 3.222

2.  Prevalence of Substance Use in Patients Diagnosed with Schizophrenia.

Authors:  Yasemin Tekin Uludağ; Gülcan Güleç
Journal:  Noro Psikiyatr Ars       Date:  2016-03-01       Impact factor: 1.339

3.  Cannabis withdrawal in chronic cannabis users with schizophrenia.

Authors:  Douglas L Boggs; Deanna L Kelly; Fang Liu; Jared A Linthicum; Hailey Turner; Jennifer R Schroeder; Robert P McMahon; David A Gorelick
Journal:  J Psychiatr Res       Date:  2012-11-10       Impact factor: 4.791

4.  Test-retest reliability of self-report measures in a dually diagnosed sample.

Authors:  Jon M Houck; Alyssa A Forcehimes; Elisa T Gutierrez; Michael P Bogenschutz
Journal:  Subst Use Misuse       Date:  2012-10-25       Impact factor: 2.164

Review 5.  An Integrative Perspective on the Role of Dopamine in Schizophrenia.

Authors:  Tiago V Maia; Michael J Frank
Journal:  Biol Psychiatry       Date:  2016-06-01       Impact factor: 13.382

6.  Rate of cannabis use disorders in clinical samples of patients with schizophrenia: a meta-analysis.

Authors:  Johanna Koskinen; Johanna Löhönen; Hannu Koponen; Matti Isohanni; Jouko Miettunen
Journal:  Schizophr Bull       Date:  2009-04-22       Impact factor: 9.306

7.  Negative symptoms are associated with less alcohol use, craving, and "high" in alcohol dependent patients with schizophrenia.

Authors:  Steven L Batki; Luba Leontieva; Jacqueline A Dimmock; Robert Ploutz-Snyder
Journal:  Schizophr Res       Date:  2008-08-13       Impact factor: 4.939

8.  Substance dependence and remission in schizophrenia: A comparison of schizophrenia and affective disorders.

Authors:  Melanie E Bennett; Alan S Bellack; Clayton H Brown; Carlo DiClemente
Journal:  Addict Behav       Date:  2009-03-27       Impact factor: 3.913

9.  Factors Affecting the Management of Somatic Comorbidity in Tunisian Patients with Schizophrenia.

Authors:  Jihene Ben Thabet; Nada Charfi; Wafa Dalhoum; Sourour Yaich; Manel Maâlej Bouali; Sana Omri; Nasreddine Zouari; Lobna Zouari; Jamel Damak; Mohamed Maâlej
Journal:  Psychiatr Q       Date:  2019-03

10.  Prevalence and risk factors of psychotic symptoms: in the city of Izmir, Turkey.

Authors:  Köksal Alptekin; Halis Ulas; Berna Binnur Akdede; Mevhibe Tümüklü; Yildiz Akvardar
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2009-03-03       Impact factor: 4.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.